Hanx Biopharmaceuticals (Wuhan) Co Ltd - Class H

NEW
HKSE:03378 (China)   Class H
HK$ 27.4 -1.44 (-4.99%) Sep 11
At Loss
P/B:
5.04
Market Cap:
HK$ 3.67B ($ 468.39M)
Enterprise V:
HK$ 3.18B ($ 405.30M)
Volume:
4.30K
Avg Vol (2M):
50.81K
Trade In:
Volume:
4.30K
At Loss
Avg Vol (2M):
50.81K

Hanx Biopharmaceuticals (Wuhan) Co Ltd (HKSE:03378) Dividend

Hanx Biopharmaceuticals (Wuhan) Co Ltd (HKSE:03378) does not currently pay a regular dividend. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: HKSE:03378 Dividend

Does Hanx Biopharmaceuticals (Wuhan) Co Ltd (HKSE:03378) pay a dividend?

Hanx Biopharmaceuticals (Wuhan) Co Ltd (HKSE:03378) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Hanx Biopharmaceuticals (Wuhan) Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks.

What are dividend-paying alternatives to Hanx Biopharmaceuticals (Wuhan) Co Ltd?

For dividend-paying alternatives in Hanx Biopharmaceuticals (Wuhan) Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.